phase 2_completion
saveWuhan Union Hospital — cadonilimab (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Metastatic Breast Cancer, Triple-Negative Breast Cancer (TNBC)